Thermoregulation, the process by which the body maintains its internal temperature within a narrow range, is vital for normal physiological functioning. Under normal conditions, the body uses a combination of autonomic and behavioral responses to maintain a stable core temperature. However, in the perioperative setting, the body's thermoregulatory capacity is compromised due to the effects of anesthesia and the cold operating room environment. Anesthesia providers must monitor and intervene proactively to prevent temperature disturbances during surgery, as both hypothermia and hyperthermia can have serious consequences for patient outcomes.
Impaired Thermoregulation Under Anesthesia
Anesthesia affects thermoregulation in several key ways. First, it widens the interthreshold range, the band of core temperatures across which no autonomic defense is triggered. Awake, this range is only about 0.2 C wide, so the hypothalamus responds to slight decreases in core temperature by initiating vasoconstriction in the periphery to conserve heat and, if necessary, by triggering shivering to generate additional heat through muscle activity. Under general anesthesia the vasoconstriction and shivering thresholds fall by 2 to 3 C while the sweating threshold rises slightly, so the range widens to roughly 4 C (about 34.5 to 38 C). Within that band the patient is effectively poikilothermic: the compensatory responses do not appear until core temperature has already fallen well below normal, making patients more susceptible to unintended hypothermia.
The effects of general anesthesia on thermoregulation are compounded by the cold environment of the operating room. Operating rooms are typically maintained at a cool temperature, mainly to keep surgical teams comfortable under sterile gowns and equipment. This cool environment promotes heat loss in patients through radiation (the largest share), convection, evaporation, and conduction, all of which are exacerbated by the exposure of large surface areas during surgery. Additional heat loss occurs through the use of cold intravenous fluids and inhaled anesthetic gasses, which are not warmed to match the patient’s body temperature.
Regional anesthesia, while it has different systemic effects compared to general anesthesia, can also impair thermoregulation. For instance, spinal and epidural anesthesia impair thermoregulation both peripherally and centrally. Peripherally, the block interrupts the efferent sympathetic and motor pathways, so the legs can neither vasoconstrict nor shiver. Centrally, the hypothalamus misreads the loss of tonic cold signals from the blocked region as warmth and lowers the vasoconstriction and shivering thresholds by about 0.5 to 1 C, so the remaining upper-body defenses are triggered late. Redistribution hypothermia follows the sympathetic block just as it does after induction of general anesthesia, and because the patient may feel warm and core temperature is monitored less often under regional anesthesia, this hypothermia frequently goes unrecognized. In both types of anesthesia, the risk of perioperative hypothermia is high, and proactive measures must be taken to counteract the heat loss.
Perioperative Hypothermia and Its Consequences
Perioperative hypothermia is one of the most common complications during surgery and anesthesia, defined as a core body temperature below 36°C. It typically occurs in three phases: redistribution, linear heat loss, and plateau. Redistribution hypothermia occurs soon after induction, when anesthetics cause vasodilation and allow core heat to flow into the cooler periphery; core temperature falls by about 1 to 1.6 C during the first hour, and this phase accounts for most of the total drop. In the second phase, over the next 2 to 3 hours, core temperature falls more slowly and roughly linearly because heat loss to the environment, cold instruments, and fluids exceeds the reduced metabolic heat production. After 3 to 4 hours a plateau is reached, typically near 34.5 C, when core temperature finally falls to the lowered vasoconstriction threshold and the reemerging vasoconstriction confines metabolic heat to the core.
The consequences of hypothermia are significant and wide-ranging. Cardiovascularly, hypothermia increases the risk of arrhythmias and myocardial ischemia. As body temperature drops, the release of catecholamines (such as epinephrine) increases, leading to tachycardia and hypertension. In severe cases, these changes can provoke life-threatening arrhythmias. Additionally, patients with preexisting cardiac conditions are at a heightened risk if perioperative hypothermia is not managed: in a randomized trial of high-risk patients, Frank and colleagues (1997) found morbid cardiac events (unstable angina or ischemia, cardiac arrest, or myocardial infarction) in 6.3% of patients who were allowed to drift about 1.3 C below normal versus 1.4% of those kept normothermic, and ventricular tachycardia was roughly three times as frequent.
Hypothermia also has profound effects on coagulation and immune function. It impairs platelet aggregation and disrupts the enzymatic pathways involved in clotting, leading to increased intraoperative bleeding and a greater need for blood transfusions; in a meta-analysis of randomized trials, even mild hypothermia (a core temperature about 1 C below normal) increased blood loss by approximately 16% and the relative risk of transfusion by about 22%. Because standard coagulation tests are run at 37 C, they do not reveal the defect. Postoperative bleeding and hematoma formation are more common in hypothermic patients, further increasing the risk of complications. Immune function is similarly affected, as hypothermia reduces tissue oxygenation, impairs neutrophil activity, and increases the risk of surgical site infections. Studies have shown that even mild perioperative hypothermia is associated with a significantly higher rate of postoperative infections, which can delay healing and increase hospital length of stay. In the landmark trial by Kurz and colleagues (1996), colorectal surgery patients allowed to drift to a mean core temperature of 34.7 C had three times the surgical wound infection rate of actively warmed patients (19% versus 6%) and stayed in hospital about 2.6 days (20%) longer.
Moreover, hypothermia delays drug metabolism, particularly the metabolism of anesthetic agents, resulting in prolonged recovery times. This occurs because enzymatic activity is temperature-dependent, and cooler body temperatures slow the breakdown of drugs in the liver. For example, a core temperature 2 C below normal roughly doubles the duration of action of vecuronium, mild hypothermia raises the plasma concentration of propofol by about 30% at a constant infusion rate, and the MAC of volatile anesthetics falls by roughly 5% per degree Celsius. Patients who experience perioperative hypothermia often require extended time in the post-anesthesia care unit (PACU), delaying emergence from anesthesia and increasing the likelihood of postoperative sedation and respiratory depression.
| Domain | What happens |
|---|---|
| How it develops | Three phases: redistribution of core heat to the periphery soon after induction as anesthetics cause vasodilation (core falls 1 to 1.6 C in the first hour), then slower linear loss to the environment and to cold instruments and fluids over 2 to 3 hours, then a plateau near 34.5 C once vasoconstriction reemerges. |
| Cardiovascular | Catecholamine release rises, producing tachycardia and hypertension; arrhythmias and myocardial ischemia become more likely, and patients with preexisting cardiac disease are at heightened risk of myocardial infarction. |
| Coagulation | Platelet aggregation is impaired and the enzymatic clotting pathways are disrupted, increasing intraoperative bleeding, transfusion requirement, and postoperative bleeding or hematoma. |
| Immune function and wounds | Tissue oxygenation falls and neutrophil activity is impaired; even mild hypothermia carries a significantly higher rate of surgical site infection, delaying healing and lengthening hospital stay. |
| Drug metabolism | Enzymatic activity is temperature-dependent, so hepatic breakdown of anesthetic agents slows — delayed emergence, extended PACU time, and more postoperative sedation and respiratory depression. |
| Postoperative shivering | Common after intraoperative hypothermia and raises oxygen consumption (typically about twofold), which may not be tolerated by patients with underlying respiratory or cardiovascular disease; treat with forced-air rewarming and meperidine 12.5 to 25 mg IV. |
| Regional anesthesia | Spinal and epidural blocks interrupt the efferent pathways for vasoconstriction and shivering below the block and lower the central thresholds by about 0.5 to 1 C, so the risk is high with regional technique as well as with general anesthesia, and it is often unrecognized because core temperature is monitored less often. |
Hyperthermia and Malignant Hyperthermia
While hypothermia is more common, perioperative hyperthermia can also pose a significant threat, particularly in the form of malignant hyperthermia (MH). MH is a rare but life-threatening condition triggered by certain anesthetic agents, including volatile anesthetics and the depolarizing muscle relaxant succinylcholine. In susceptible individuals, these drugs cause a hypermetabolic state characterized by a rapid and uncontrolled rise in body temperature, muscle rigidity, and severe metabolic disturbances. Without prompt intervention, MH can lead to rhabdomyolysis, hyperkalemia, acidosis, and multi-organ failure.
Early recognition of MH is critical. A rising temperature is usually a late sign; the earliest clues are an unexplained rise in end-tidal CO2 that persists despite increased ventilation, tachycardia, and masseter or generalized muscle rigidity, so anesthesia providers must be vigilant whenever volatile anesthetics or succinylcholine have been given. Treatment involves the immediate cessation of the triggering agents, hyperventilation with 100% oxygen at high fresh gas flows, and the administration of dantrolene, a ryanodine receptor antagonist that stops the uncontrolled release of calcium from skeletal muscle: 2.5 mg/kg IV, repeated every few minutes until the hypermetabolic signs resolve (a cumulative dose above 10 mg/kg is occasionally needed). Cooling measures, such as ice packs, cold intravenous fluids, and lavage of open body cavities, should be started when core temperature exceeds about 39 C and stopped once it falls to 38 C to avoid overshoot hypothermia. The MHAUS hotline (1-800-644-9737 in the United States) provides expert guidance in real time.
In non-MH cases, hyperthermia may result from other causes, such as fever, infection, or excessive heating during surgery. Regardless of the cause, anesthesia providers must monitor core body temperature throughout the perioperative period to detect and address any deviations from normothermia, whether it is hypothermia or hyperthermia. Core temperature should be monitored continuously in any patient receiving general anesthesia for more than about 30 minutes and in patients having major surgery under neuraxial anesthesia. Reliable core sites are the pulmonary artery, distal esophagus, nasopharynx (probe advanced 10 to 20 cm), and tympanic membrane; bladder and rectal temperatures lag behind during rapid change, and skin-surface and infrared forehead readings are not accurate enough to guide intraoperative care. The goal is a core temperature of at least 36 C throughout the perioperative period.
